Home > Healthcare > Medical Devices > Diagnostic Devices > Preterm Birth Diagnostic Test Kits Market

Preterm Birth Diagnostic Test Kits Market Share

Report ID: GMI4044
Published Date: May 2023
Report Format: PDF

Download Free Sample

Preterm Birth Diagnostic Test Kits Market Share

Some of the notable key industry players operating in the preterm birth diagnostic test kits industry include:

Abbott
Creative Diagnostics
Clinical Innovations
Hologic
IQ Products
Qiagen
Medixbiochemica
Biosynex
CooperSurgical Inc
Sera Progonstics
Stryker Corporation

These market participants are implementing various growth strategies such as collaborations, partnerships, acquisitions & mergers, and new product development and launches to strengthen product type offerings as well as gain a competitive edge over others.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market size for preterm birth diagnostic test kits was valued at over USD 419 million in 2022 and is projected to reach more than USD 856 million by 2032, owing to high incidence of preterm births, along with increasing awareness about early detection of fetal anomalies.

Fetal fibronectin test kits (fFN) segment held the largest revenue size over USD 197 million in 2022 and will grow significantly through 2032, on account of high sensitivity of the test in detecting the presence of fetal fibronectin, a protein that acts as a biomarker for preterm birth.

U.S. market for preterm birth diagnostic test kits accounted for more than USD 158 million in 2022 and will gather more than USD 344 million by 2032. The affordability of preterm birth diagnostic test kits and ongoing technological developments are primarily responsible for the regional market growth.

Abbott, Creative Diagnostics, Clinical Innovations, Hologic, IQ Products, Qiagen, Medixbiochemica, Biosynex, CooperSurgical Inc, Sera Progonstics, and Stryker Corporation among others.